Tilray Stock News

InvestorPlace - Stock Market News, Stock Advice & Trading Tips But despite the near constant bad news for the cannabis industry, aggressive investors should still buy TLRY stock under $11. The post Tilray Has More Bad News Harshing Their Mellow appeared first on InvestorPlace . More From InvestorPlace Stock Prodigy Who Found NIO at $2 Says Buy THIS Now Man Who Called Black Monday: Prepare Now. #1 EV Stock Still Flying Under the Radar Interested in Crypto? Read This First

NEW YORK , Nov. 15, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CSPR, EYPT, TLRY, ONDS, and HEXO. … Full story available on Benzinga.com

On Sunday evening, Benzinga asked its followers on Twitter what stock theyre buying at the open on Monday. From the replies, Benzinga selected one ticker for technical analysis. @kukovisuals , @JasonWe80277557 , @FlatTrading and @pvvardhanreddy are buying Tilray, Inc (NASDAQ: TLRY ). On Friday, President Joe Biden announced he intends to nominate Robert Califf as the new Food and Drug Administration (FDA) commissioner. Califf, who briefly headed the FDA under the Obama administration, has previously said he prescribed a cannabinoid drug as a doctor and has acknowledged the potential medical benefits of cannabis. The announcement coincided with a typically bullish season in the cannabis sector and last week many individual names such as the cannabis space leader Canopy Growth Corporation (NASDAQ: CGC ) reversed into an uptrend and broke through a key resistance level near the $15 mark. Tilray , a Canadian-based cannabis giant, also broke up bullishly from a pattern and bust through a resistance area at the $12.54 level,